We will continue to prune our product portfolio. We had more than 300 actives in 2000, and target about 100 actives for 2006, a further reduction of about 25% compared to the end of 2005. Ultimately we will focus on about 60 core active ingredients. |
We're waiting to see how it plays out, but right now it appears that the preference is for an interim capability followed much later - possibly around 2030 - by a supersonic or hypersonic capability. |
With this EBITDA margin we have once again set a profitability benchmark in our industry. |